Clinical Trials Logo

Language Development Disorders clinical trials

View clinical trials related to Language Development Disorders.

Filter by:

NCT ID: NCT04100863 Recruiting - Clinical trials for Autism Spectrum Disorder

A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Autism

Start date: March 2, 2020
Phase:
Study type: Observational [Patient Registry]

This study seeks to correlate microbiome sequencing data with information provided by patients and their medical records regarding autism.

NCT ID: NCT04066049 Recruiting - Clinical trials for Language Development Disorders

EMT en Español for Spanish-speaking Toddlers With Language Delays

Start date: December 1, 2019
Phase: N/A
Study type: Interventional

The goal of the study is to conduct an initial efficacy study of a promising therapist and caregiver-implemented communication intervention to improve language and school readiness skills in low-income Spanish-speaking children with receptive and expressive language delays (ages 30 to 36 months). The proposed randomized trial compares the effects of a caregiver plus therapist implemented EMT en Español intervention to a community based "business as usual" control group at four time points (pre- intervention, post-intervention, 6 month follow-up, 12 month follow-up) in a sample of 84 low-income, Spanish-speaking families and their toddlers with receptive and expressive language delays.

NCT ID: NCT03586479 Recruiting - Clinical trials for Language Development Disorders

Kindergarten Children Acquiring Words Through Storybook Reading

KAWStory
Start date: July 2, 2018
Phase: N/A
Study type: Interventional

Children with Specific Language Impairment (SLI) are slower to learn new words than their peers, placing them at risk for academic failure. In this study, we are improving a storybook reading treatment to help Kindergarten children with SLI learn new words. In this study, we compare three versions of book reading that vary in how often children are tested on, meaning asked to talk about, the words they are learning in the book: low vs. mid vs. high testing. We then examine which version of the treatment leads to better learning of the words during treatment and remembering of the words after treatment. We also seek to understand individual differences in treatment outcomes by examining pre-treatment predictors as well as progress during and after treatment.

NCT ID: NCT03525951 Recruiting - Clinical trials for Autism Spectrum Disorder

Parent-Level Predictors of Early Language Interaction Quality and Intervention Outcomes

Start date: March 22, 2021
Phase: N/A
Study type: Interventional

Children with poor early language skills are at risk for academic, social, vocational, and health difficulties across the lifespan. Parent training-as part of early language intervention-is a cost-effective option to address this public health issue, but these interventions demonstrate large individual differences in outcomes and barriers to scalability. The purpose of this research is to examine parent-level predictors of early language interaction quality and modifiability during training, which will help increase intervention effectiveness.

NCT ID: NCT02609542 Recruiting - Clinical trials for Language Development Disorders

Memorisation of Phonologic Information Among Children With Oral Language Developement Disorder

MEMENTO
Start date: March 2014
Phase:
Study type: Observational

The disorder of oral language development is defined by the delay in language acquisition in children who possess efficient auditory acuity and normal non verbal intellect. The diversity of language developement disorders depends either in the expressive level or in the receptive level leading to divers syndromes and symptoms. These syndromes and symptoms are regrouped under the name of STOL (Specific Troubles of Oral Language). In the current project the visual exploitation and learning capability of children presenting a STOL condition will be compared to patients with a normal development. The investigator's hypothesis is as follows: STOL patients for whom the STOL disorder is reduced between 4 and 7 years of age will present a better performance at verbal memorisation, compared to patients with a persistent STOL condition after the age of 6.

NCT ID: NCT02116348 Recruiting - Clinical trials for Cerebral Palsy Children

Cerebrolysin Neural Repair Therapy in Children With Traumatic Brain Injury and Cerebral Palsy

Start date: April 2014
Phase: Phase 2
Study type: Interventional

Cerebral palsy (CP) is the most frequent cause of motor handicap among children. The economic burden of CP in USA includes $1.18 billion in direct medical costs, $1.05 billion in direct non-medical costs, and an additional $9.24 billion in indirect costs, for a total cost of $11.5 billion or $921,000 average cost per person. Associated disabilities as mental retardation, delayed speech development add psychological burden of the disease on the family as well as economic burden. Mental retardation is the major problem in children with cerebral palsy. Improving mental development will have a positive effect on quality of life for the child and his family. Treating associated impairments (mental retardation) with Cerebrolysin will improve mental development and quality of life, and will decrease the economic burden in children with cerebral palsy.